Seah, J.-A., Sridhar, S., Wood, L., Blais, N., North, S., Rahim, Y., Ruether, D., Black, P. and Zlotta, A.R. 2013. Neoadjuvant chemotherapy (NC) should be administered to fit patients with newly diagnosed, potentially resectable muscle-invasive urothelial cancer (MIUC) of the bladder – A 2013 CAGMO Consensus Statement and Call for a Streamlined Referral Process. Canadian Urological Association Journal. 7, 9-10 (Oct. 2013), 312–8. DOI:https://doi.org/10.5489/cuaj.1506.